Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review
The published experience with biologics in childbearing age with autoimmune and inflammatory diseases mainly deals with the use of TNFα inhibitors (TNFα-i). Limited data are available for biologics targeting other cytokines or immunocompetent cells, especially for the inflammasome targeted therapy i...
Main Authors: | Carla Carnovale, Enrico Tombetti, Vera Battini, Faizan Mazhar, Sonia Radice, Mariangela Nivuori, Enrica Negro, Silvia Tamanini, Antonio Brucato |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.612259/full |
Similar Items
-
Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
by: Annika Vestergaard Kvist, et al.
Published: (2021-04-01) -
Ricin Toxin Activates the NALP3 Inflammasome
by: Meghan Lindauer, et al.
Published: (2010-06-01) -
INFLUENCE OF AN INHIBITOR OF JNK ON THE SECRETION OF THE INFLAMMASOME–DEPENDENT PROINFLAMMATORY CYTOKINES
by: Boncho Grigorov, et al.
Published: (2020-05-01) -
IL-27 Enhances LPS-Induced Proinflammatory Responses in Human Monocytes: Augmented Inflammasome Activity and IL-23 Expression
by: WYNICK, CHRISTOPHER
Published: (2014) -
NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
by: Eleonora Mezzaroma, et al.
Published: (2021-02-01)